文献速递炎症性肠病

炎症性肠病患者急诊离院时阿片类药物处方频率:一项全国性分析

Frequency of Opioid Prescription at Emergency Department Discharge in Patients with Inflammatory Bowel Disease: A Nationwide Analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-07-16

中度/重度疼痛者更可能接受阿片类(aOR 5.06),年龄较大者更不可能(每十年aOR 0.73);2015-2017年观察到下降趋势。

要点

  • 炎症性肠病患者急诊离院时阿片类处方比例为35.3%(95%CI 26.5%-45.2%)。
  • 中度/重度疼痛者接受阿片类的aOR为5.06(95%CI 1.72-14.90,p<0.01)。
  • 年龄每增加十年,接受阿片类的aOR为0.73(95%CI 0.55-0.98,p=0.04)。

核心结论

  • 超过三分之一的炎症性肠病患者在急诊离院时被处方阿片类药物,提示该人群在获得有效疼痛管理方案方面存在潜在照护缺口。

研究设计与样本

  • 对美国国家医院门诊医疗调查(NHAMCS)2006-2017年数据进行的横断面分析,纳入成人(≥18岁)炎症性肠病患者,评估急诊或急诊离院时阿片类处方比例,采用逻辑回归评估预测因素并进行时间趋势分析,所有分析均针对复杂抽样设计进行调整。

主要发现

  • 51.9%(95%CI 42.2%-61.6%)的就诊在急诊接受了阿片类药物。
  • 35.3%(95%CI 26.5%-45.2%)的炎症性肠病相关急诊离院伴随阿片类处方。
  • 中度/重度疼痛患者更可能接受阿片类药物(aOR 5.06,95%CI 1.72-14.90,p<0.01),年龄较大者更不可能接受(每十年aOR 0.73,95%CI 0.55-0.98,p=0.04)。
  • 时间分析中,2015-2017年观察到急诊阿片类使用及离院阿片类处方呈下降趋势。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) frequently experience chronic pain. Patients will often seek out care in the emergency department (ED) where short-term opioid use may be associated with potential treatment-related complications. We aimed to assess the rate and factors associated with opioid prescription in IBD patients discharged from the ED. METHODS: We conducted a cross-sectional analysis of data collected in the US National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2006-2017. We determined the proportion of adult patients (≥18 years) with IBD prescribed an opioid in ED or at ED discharge. Logistic regression was used to evaluate predictors of opioid prescription. Time-trend analysis was performed to evaluate temporal patterns in opioid use. All analyses were adjusted for complex survey design. RESULTS: We identified ∼965,000 weighted discharges from the ED for patients with IBD. In total, 51.9% [95% CI: 42.2% -61.6%] of visits resulted in opioid administration in ED and 35.3% [95% CI: 26.5% -45.2%] of IBD-related ED discharges were associated with an opioid prescription. IBD patients with moderate/severe pain (adjusted odds ratio aOR 5.06 [95% CI: 1.72 -14.90], p < 0.01) were more likely to receive opioids whereas older age (aOR 0.73 per decade [95% CI: 0.55 -0.98], p = 0.04) were less likely. In temporal analysis, a trend towards decreasing opioid use in ED and opioid prescriptions at discharge was observed in 2015-2017. CONCLUSIONS: More than one third of IBD patients are prescribed an opioid at discharge from ED, highlighting a potential gap in care for accessing effective pain management solutions in this population.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Chhibba T, Guizzetti L, Seow CH, et al. Frequency of Opioid Prescription at Emergency Department Discharge in Patients with Inflammatory Bowel Disease: A Nationwide Analysis. Clin Gastroenterol Hepatol. 2020. PMID: 32683099. doi:10.1016/j.cgh.2020.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。